T. Rowe Price Investment Management, Inc. - PACIFIC BIOSCIENCES CALIF IN ownership

PACIFIC BIOSCIENCES CALIF IN's ticker is PACB and the CUSIP is 69404D108. A total of 224 filers reported holding PACIFIC BIOSCIENCES CALIF IN in Q3 2022. The put-call ratio across all filers is 0.96 and the average weighting 0.2%.

Quarter-by-quarter ownership
T. Rowe Price Investment Management, Inc. ownership history of PACIFIC BIOSCIENCES CALIF IN
ValueSharesWeighting
Q3 2023$61,920
-24.6%
7,415,524
+20.2%
0.04%
-21.4%
Q2 2023$82,083
+30.8%
6,171,599
+13.9%
0.06%
+24.4%
Q1 2023$62,771
+26.4%
5,420,563
-10.7%
0.04%
+18.4%
Q4 2022$49,658
-99.9%
6,070,539
-19.8%
0.04%
+8.6%
Q3 2022$43,959,0007,572,5580.04%
Other shareholders
PACIFIC BIOSCIENCES CALIF IN shareholders Q3 2022
NameSharesValueWeighting ↓
ORACLE INVESTMENT MANAGEMENT INC 1,446,459$48,182,0007.22%
BOURNE LENT ASSET MANAGEMENT INC 536,800$17,881,0005.70%
Casdin Capital, LLC 5,000,000$166,550,0004.96%
Iron Triangle Partners LP 935,805$31,172,0003.96%
Jackson Square Partners, LLC 12,911,695$430,088,0002.44%
SB Management Ltd 9,861,089$328,473,0002.12%
Abacus Planning Group, Inc. 180,000$5,996,0001.92%
BERKSHIRE CAPITAL HOLDINGS INC 413,800$13,784,0001.57%
ARK Investment Management 21,301,191$709,543,0001.41%
Nikko Asset Management Americas, Inc. 5,247,237$174,785,0000.86%
View complete list of PACIFIC BIOSCIENCES CALIF IN shareholders